ArticleBMC veterinary research2025
Preliminary assessment of the leukocyte coping capacity as a point of care marker in horses with stress associated diseases.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStress represents a serious health and welfare concern; however, its objective assessment remains difficult. The equine gastric ulcer syndrome (EGUS) and orthopedic diseases that cause pain are among stress associated diseases in equine medicine. The leukocyte coping capacity (LCC) quantifies oxygen radical generation of neutrophil granulocytes which is altered under stress. Therefore, LCC could be a novel biomarker for stress in horses and we hypothesized that horses with stress associated diseases would have lower LCC values in comparison to horses without these diseases. MATERIALS AND
methodsIn this observational clinical pilot study, 45 privately owned horses were classified according to the most relevant clinical diagnosis based on clinical, laboratory and gastroscopic findings into the following groups: (1) No EGUS; no clinical and/or laboratory and/or gastroscopic signs of EGUS, lameness or other diseases, (2) EGUS; any grade of EGUS, but no clinical and/or laboratory signs of lameness or other diseases, (3) Lameness; any grad of lameness, but no clinical and/or laboratory signs other diseases, any grade of EGUS possible, (4) Other diseases; identified based on abnormal findings in clinical examination and/or laboratory work, with no evidence of lameness, any grade of EGUS possible. The LCC was measured at first visit (T1) and 28 days later (T2) and the values compared among the groups with mean comparison tests and mixed effect models for repeated measures.
resultsPrimary results indicate that horses in group 3 had significantly (P = 0.012) lower values for LCC compared to horses in the group 1 at T1. Also group 3 horses had highest EGUS scores. At T2 LCC was still significantly lower in this group (P = 0.031), even though the severity of EGUS decreased in all horses with treatment (P = 0.004).
conclusionLame horses had higher EGUS scores and lower LCC levels, indicating a possible link between lameness, EGUS, and stress. Our findings support further investigation into the use of LCC as a quantitative immunological marker of stress with strong potential for use at point of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.